Skip to main content

Advertisement

Log in

Antireflux Surgery for Dysplastic Barrett

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Introduction

Barrett’s esophagus (BE) is the result of continuous injury of the esophageal mucosa by gastric refluxate. This condition can progress to low-grade (LGD) and high-grade dysplasia (HGD) and eventually to adenocarcinoma. While excellent results are reported in terms of reflux and symptom control in patients with BE undergoing antireflux surgery (ARS), the impact of a fundoplication on progression and regression of dysplasia is debated. The aim of this article is to review the effects of ARS on regression and progression of LGD to HGD or cancer in patients with dysplastic BE.

Materials and Methods

A review of the literature in PubMed/Medline electronic databases has been performed.

Results

ARS might decrease but not eliminate the risk of progression to dysplasia or cancer in BE patients. ARS may promote regression of dysplastic BE only in short-segment BE, but not in long-segment BE. Modulation of gene expression is involved in the genesis and reversion of short-segment intestinal metaplasia after ARS.

Conclusions

Close and long-term surveillance by 24-hour pH monitoring and upper endoscopy is recommended in BE patients who undergo ARS to identify postoperative pathological reflux, and to early detect dysplasia or even adenocarcinoma. Further studies are requested to assess the molecular effects of ARS in dysplastic BE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dent J, El Serag HB, Wallander MA et al (2005) Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 54:710–717

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Patti MG, Arcerito M, Feo CV et al (1999) Barrett’s esophagus: a surgical disease. J Gastrointest Surg 3:397–403

    Article  CAS  PubMed  Google Scholar 

  3. Rugge M, Zaninotto G, Parente P et al (2012) Barrett’s esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA). Ann Surg 256:788–794

    Article  PubMed  Google Scholar 

  4. Oh DS, DeMeester SR (2010) Pathophysiology and treatment of Barrett’s esophagus. World J Gastroenterol 16:3762–3772

    Article  PubMed Central  PubMed  Google Scholar 

  5. Dallemagne B, Weerts J, Markiewicz S et al (2006) Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc 20:159–165

    Article  CAS  PubMed  Google Scholar 

  6. Parrilla P, Martinez de Haro LF, Ortiz A et al (2003) Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg 237:291–298

    PubMed Central  PubMed  Google Scholar 

  7. Katz PO, Zavala S (2010) Proton pump inhibitors in the management of GERD. J Gastrointest Surg 14(Suppl 1):S62–S66

    Article  PubMed  Google Scholar 

  8. Tamhankar AP, Peters JH, Portale G et al (2004) Omeprazole does not reduce gastroesophageal reflux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg 8:890–897

    Article  PubMed  Google Scholar 

  9. Blonski W, Vela MF, Castell DO (2009) Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy. J Clin Gastroenterol 43:816–820

    Article  PubMed  Google Scholar 

  10. Tutuian R, Vela MF, Hill EG et al (2008) Characteristics of symptomatic reflux episodes on acid suppressive therapy. Am J Gastroenterol 103:1090–1096

    Article  PubMed  Google Scholar 

  11. Corly DA, Kubo A, Zhao W et al (2010) Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology 139:93–101

    Article  Google Scholar 

  12. Abraham NS (2012) Proton pump inhibitors: potential adverse effects. Curr Opin Gastroenterol 28:615–620

    Article  CAS  PubMed  Google Scholar 

  13. Herbella FA, Tedesco P, Nipomnick I et al (2007) Effect of partial and total laparoscopic fundoplication on esophageal body motility. Surg Endosc 21:285–288

    Article  CAS  PubMed  Google Scholar 

  14. Katzka DA, Castell DO (1994) Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett’s esophagus. Am J Gastroenterol 89:989–991

    CAS  PubMed  Google Scholar 

  15. Attwood SE, Lundell L, Hatlebakk JG et al (2008) Medical or surgical management of GERD patients with Barrett’s esophagus: the LOTUS trial 3-year experience. J Gastrointest Surg 12:1646–1654

    Article  CAS  PubMed  Google Scholar 

  16. Kauer WK, Peters JH, DeMeester TR et al (1995) Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 222:525–531

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. McCallum R, Polepalle S, Davenport K et al (1991) Role of anti-reflux surgery against dysplasia in Barrett’s esophagus. Gastroenterology 100:A121

    Google Scholar 

  18. Katz D, Rothstein R, Schned A et al (1998) The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett’s esophagus. Am J Gastroenterol 93:536–541

    Article  CAS  PubMed  Google Scholar 

  19. Ortiz A, Martinez de Haro LF, Parrilla P et al (1996) Conservative treatment versus antireflux surgery in Barrett’s oesophagus: long-term results of a prospective study. Br J Surg 83:274–278

    Article  CAS  PubMed  Google Scholar 

  20. Öberg S, Wenner J, Johansson J et al (2005) Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann Surg 242:49–54

    Article  PubMed Central  PubMed  Google Scholar 

  21. Oelschlager BK, Barreca M, Chang L et al (2003) Clinical and pathologic response of Barrett’s esophagus to laparoscopic antireflux surgery. Ann Surg 238:458–464

    PubMed Central  PubMed  Google Scholar 

  22. Chang EY, Morris CD, Seltman AK et al (2007) The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett esophagus: a systematic review. Ann Surg 246:11–21

    Article  PubMed Central  PubMed  Google Scholar 

  23. Csendes A, Burdiles P, Braghetto I et al (2002) Dysplasia and adenocarcinoma after classic antireflux surgery in patients with Barrett’s esophagus: the need for long-term subjective and objective follow-up. Ann Surg 235:178–185

    Article  PubMed Central  PubMed  Google Scholar 

  24. O’Riordan JM, Byrne PJ, Ravi N et al (2004) Long-term clinical and pathologic response of Barrett’s esophagus after antireflux surgery. Am J Surg 188:27–33

    Article  PubMed  Google Scholar 

  25. Lagergren J, Viklund P (2007) Is esophageal adenocarcinoma occurring late after antireflux surgery due to persistent postoperative reflux? World J Surg 31:465–469

    Article  PubMed  Google Scholar 

  26. Zehetner J, deMeester SR, Ayazi S et al (2010) Long-term follow-up after anti-reflux surgery in patients with Barrett’s esophagus. J Gastrointest Surg 14:1483–1491

    Article  PubMed  Google Scholar 

  27. Wang KK, Sampliner RE (2008) Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol 103:788–797

    Article  PubMed  Google Scholar 

  28. Gurski RR, Peters JH, Hagen JA et al (2003) Barrett’s esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg 196:706–712

    Article  PubMed  Google Scholar 

  29. Rossi M, Barreca M, de Bortoli N et al (2006) Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus. A prospective study. Ann Surg 243:58–63

    Google Scholar 

  30. Oh DS, DeMeester SR, Vallbohmer D et al (2007) Reduction of interleukin-8 gene expression in reflux esophagitis and Barrett’s esophagus with antireflux surgery. Arch Surg 142:554–559

    Article  CAS  PubMed  Google Scholar 

  31. Babar M, Ennis D, Abdel-Latif M et al (2010) Differential molecular changes in patients with asymptomatic long-segment Barrett’s esophagus treated by antireflux surgery or medical therapy. Am J Surg 199:137–143

    Article  PubMed  Google Scholar 

  32. Zaninotto G, Cassaro M, Pennelli G et al (2005) Barrett’s epithelium after antireflux surgery. J Gastrointest Surg 9:1253–1261

    Article  PubMed  Google Scholar 

  33. Zaninotto G, Parente P, Salvador R et al (2012) Long-term follow-up of Barrett’s epithelium: medical versus antireflux surgical therapy. J Gastrointest Surg 16:7–14

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have no conflicts of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marco G. Patti.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Allaix, M.E., Patti, M.G. Antireflux Surgery for Dysplastic Barrett. World J Surg 39, 588–594 (2015). https://doi.org/10.1007/s00268-014-2632-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-014-2632-x

Keywords

Navigation